Cumulative incidence of cause-specific death at 5 years stratified by donor type
| Cause . | Sibling donor (N = 53), CI (95%) . | Unrelated donor (N = 102), CI (95%) . | Haploidentical donor (N = 35), CI (95%) . | Unrelated vs sibling HR (CI), P . | Haplo vs sibling HR (CI), P . |
|---|---|---|---|---|---|
| GVHD | 6.6 (1.6-16.6) | 7.0 (3.03-13.2) | 3.4 (0.22-15.5) | 1.28 (0.3-4.9), .72 | 0.48 (0.1-4.6), .52 |
| Infection | 12.7 (4.9-24.2) | 10.2 (5.2-17.2) | 9.1 (2.25-22) | 0.90 (0.3-2.5), .85 | 0.71 (0.2-2.8), .63 |
| Regimen toxicity | 16.0 (7.3-27.6) | 17.1 (10.4-25.2) | 14.8 (5.3-28.8) | 1.19 (0.5-2.7), .69 | 0.88 (0.3-2.7), .83 |
| Relapse | 19.7 (9.9-31.8) | 20.1 (12.6-28.9) | 14.7 (3.7-27.3) | 1.09 (0.5-2.3), .83 | 0.68 (0.2-2.0), .49 |
| Cause . | Sibling donor (N = 53), CI (95%) . | Unrelated donor (N = 102), CI (95%) . | Haploidentical donor (N = 35), CI (95%) . | Unrelated vs sibling HR (CI), P . | Haplo vs sibling HR (CI), P . |
|---|---|---|---|---|---|
| GVHD | 6.6 (1.6-16.6) | 7.0 (3.03-13.2) | 3.4 (0.22-15.5) | 1.28 (0.3-4.9), .72 | 0.48 (0.1-4.6), .52 |
| Infection | 12.7 (4.9-24.2) | 10.2 (5.2-17.2) | 9.1 (2.25-22) | 0.90 (0.3-2.5), .85 | 0.71 (0.2-2.8), .63 |
| Regimen toxicity | 16.0 (7.3-27.6) | 17.1 (10.4-25.2) | 14.8 (5.3-28.8) | 1.19 (0.5-2.7), .69 | 0.88 (0.3-2.7), .83 |
| Relapse | 19.7 (9.9-31.8) | 20.1 (12.6-28.9) | 14.7 (3.7-27.3) | 1.09 (0.5-2.3), .83 | 0.68 (0.2-2.0), .49 |